Cargando…

Development of Clostridium saccharoperbutylacetonicum as a Whole Cell Biocatalyst for Production of Chirally Pure (R)-1,3-Butanediol

Chirally pure (R)-1,3-butanediol ((R)-1,3-BDO) is a valuable intermediate for the production of fragrances, pheromones, insecticides and antibiotics. Biotechnological production results in superior enantiomeric excess over chemical production and is therefore the preferred production route. In this...

Descripción completa

Detalles Bibliográficos
Autores principales: Grosse-Honebrink, Alexander, Little, Gareth T., Bean, Zak, Heldt, Dana, Cornock, Ruth H. M., Winzer, Klaus, Minton, Nigel P., Green, Edward, Zhang, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155681/
https://www.ncbi.nlm.nih.gov/pubmed/34055760
http://dx.doi.org/10.3389/fbioe.2021.659895
_version_ 1783699261976739840
author Grosse-Honebrink, Alexander
Little, Gareth T.
Bean, Zak
Heldt, Dana
Cornock, Ruth H. M.
Winzer, Klaus
Minton, Nigel P.
Green, Edward
Zhang, Ying
author_facet Grosse-Honebrink, Alexander
Little, Gareth T.
Bean, Zak
Heldt, Dana
Cornock, Ruth H. M.
Winzer, Klaus
Minton, Nigel P.
Green, Edward
Zhang, Ying
author_sort Grosse-Honebrink, Alexander
collection PubMed
description Chirally pure (R)-1,3-butanediol ((R)-1,3-BDO) is a valuable intermediate for the production of fragrances, pheromones, insecticides and antibiotics. Biotechnological production results in superior enantiomeric excess over chemical production and is therefore the preferred production route. In this study (R)-1,3-BDO was produced in the industrially important whole cell biocatalyst Clostridium saccharoperbutylacetonicum through expression of the enantio-specific phaB gene from Cupriavidus necator. The heterologous pathway was optimised in three ways: at the transcriptional level choosing strongly expressed promoters and comparing plasmid borne with chromosomal gene expression, at the translational level by optimising the codon usage of the gene to fit the inherent codon adaptation index of C. saccharoperbutylacetonicum, and at the enzyme level by introducing point mutations which led to increased enzymatic activity. The resulting whole cell catalyst produced up to 20 mM (1.8 g/l) (R)-1,3-BDO in non-optimised batch fermentation which is a promising starting position for economical production of this chiral chemical.
format Online
Article
Text
id pubmed-8155681
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-81556812021-05-28 Development of Clostridium saccharoperbutylacetonicum as a Whole Cell Biocatalyst for Production of Chirally Pure (R)-1,3-Butanediol Grosse-Honebrink, Alexander Little, Gareth T. Bean, Zak Heldt, Dana Cornock, Ruth H. M. Winzer, Klaus Minton, Nigel P. Green, Edward Zhang, Ying Front Bioeng Biotechnol Bioengineering and Biotechnology Chirally pure (R)-1,3-butanediol ((R)-1,3-BDO) is a valuable intermediate for the production of fragrances, pheromones, insecticides and antibiotics. Biotechnological production results in superior enantiomeric excess over chemical production and is therefore the preferred production route. In this study (R)-1,3-BDO was produced in the industrially important whole cell biocatalyst Clostridium saccharoperbutylacetonicum through expression of the enantio-specific phaB gene from Cupriavidus necator. The heterologous pathway was optimised in three ways: at the transcriptional level choosing strongly expressed promoters and comparing plasmid borne with chromosomal gene expression, at the translational level by optimising the codon usage of the gene to fit the inherent codon adaptation index of C. saccharoperbutylacetonicum, and at the enzyme level by introducing point mutations which led to increased enzymatic activity. The resulting whole cell catalyst produced up to 20 mM (1.8 g/l) (R)-1,3-BDO in non-optimised batch fermentation which is a promising starting position for economical production of this chiral chemical. Frontiers Media S.A. 2021-05-13 /pmc/articles/PMC8155681/ /pubmed/34055760 http://dx.doi.org/10.3389/fbioe.2021.659895 Text en Copyright © 2021 Grosse-Honebrink, Little, Bean, Heldt, Cornock, Winzer, Minton, Green and Zhang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Bioengineering and Biotechnology
Grosse-Honebrink, Alexander
Little, Gareth T.
Bean, Zak
Heldt, Dana
Cornock, Ruth H. M.
Winzer, Klaus
Minton, Nigel P.
Green, Edward
Zhang, Ying
Development of Clostridium saccharoperbutylacetonicum as a Whole Cell Biocatalyst for Production of Chirally Pure (R)-1,3-Butanediol
title Development of Clostridium saccharoperbutylacetonicum as a Whole Cell Biocatalyst for Production of Chirally Pure (R)-1,3-Butanediol
title_full Development of Clostridium saccharoperbutylacetonicum as a Whole Cell Biocatalyst for Production of Chirally Pure (R)-1,3-Butanediol
title_fullStr Development of Clostridium saccharoperbutylacetonicum as a Whole Cell Biocatalyst for Production of Chirally Pure (R)-1,3-Butanediol
title_full_unstemmed Development of Clostridium saccharoperbutylacetonicum as a Whole Cell Biocatalyst for Production of Chirally Pure (R)-1,3-Butanediol
title_short Development of Clostridium saccharoperbutylacetonicum as a Whole Cell Biocatalyst for Production of Chirally Pure (R)-1,3-Butanediol
title_sort development of clostridium saccharoperbutylacetonicum as a whole cell biocatalyst for production of chirally pure (r)-1,3-butanediol
topic Bioengineering and Biotechnology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155681/
https://www.ncbi.nlm.nih.gov/pubmed/34055760
http://dx.doi.org/10.3389/fbioe.2021.659895
work_keys_str_mv AT grossehonebrinkalexander developmentofclostridiumsaccharoperbutylacetonicumasawholecellbiocatalystforproductionofchirallypurer13butanediol
AT littlegaretht developmentofclostridiumsaccharoperbutylacetonicumasawholecellbiocatalystforproductionofchirallypurer13butanediol
AT beanzak developmentofclostridiumsaccharoperbutylacetonicumasawholecellbiocatalystforproductionofchirallypurer13butanediol
AT heldtdana developmentofclostridiumsaccharoperbutylacetonicumasawholecellbiocatalystforproductionofchirallypurer13butanediol
AT cornockruthhm developmentofclostridiumsaccharoperbutylacetonicumasawholecellbiocatalystforproductionofchirallypurer13butanediol
AT winzerklaus developmentofclostridiumsaccharoperbutylacetonicumasawholecellbiocatalystforproductionofchirallypurer13butanediol
AT mintonnigelp developmentofclostridiumsaccharoperbutylacetonicumasawholecellbiocatalystforproductionofchirallypurer13butanediol
AT greenedward developmentofclostridiumsaccharoperbutylacetonicumasawholecellbiocatalystforproductionofchirallypurer13butanediol
AT zhangying developmentofclostridiumsaccharoperbutylacetonicumasawholecellbiocatalystforproductionofchirallypurer13butanediol